All Posts By

Smartkarma Daily Briefs

Daily Brief Equity Bottom-Up: Metaplanet (3350) | When the Bitcoin Flywheel Stops Spinning and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Metaplanet (3350) | When the Bitcoin Flywheel Stops Spinning
  • Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!
  • Primer: Macbee Planet (7095 JP) – Oct 2025
  • Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025
  • USG 1:1 Rule on Semi Manufacturing: Not a Clear Positive to Intel but Clearly Positive to TSMC
  • Long Woodside (WDS AU), Short Ampol (ALD AU): Statistical Spread Hits Trigger in Aussie Energy Pair
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025
  • Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?
  • Long ICICI (ICICIBC IN), Short HDFC (HDFCB IN): Fresh Statistical Arbitrage Signal in Indian Banks
  • Intel: Money Only Solves Half the Problem. The 1:1 Domestic-To-Import Ratio Not a Clear Positive


Metaplanet (3350) | When the Bitcoin Flywheel Stops Spinning

By Mark Chadwick

  • Equity-Funded Bitcoin accumulation stalls, as Metaplanet’s share price and mNAV collapse, closing the window for reflexive BTC yield growth
  • BIG trading desk delivers outsized returns, but sustainability remains uncertain amid falling Bitcoin volatility and rising funding obligations.
  • Phase II pivots toward platform ambitions, signalling a shift from accumulation to architecture, and potentially, from treasury to Bitcoin bank.

Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!

By Baptista Research

  • Rocket Lab has taken a significant strategic step toward becoming a fully vertically integrated space company with its intent to acquire a controlling stake in Mynaric AG, a German-based laser communications provider.
  • The deal, still subject to regulatory and restructuring approvals, comes on the heels of Rocket Lab’s Q2 2025 earnings, where the company reported $39.6 million in revenue and reiterated its commitment to expanding across the entire space value chain.
  • If completed, the acquisition will give Rocket Lab access to Mynaric’s production capabilities, intellectual property, and workforce of over 300 engineers.

Primer: Macbee Planet (7095 JP) – Oct 2025

By αSK

  • Macbee Planet is a high-growth marketing technology company specializing in data-driven LTV (Lifetime Value) marketing, a niche that offers significant upside within Japan’s large internet advertising market.
  • The company has demonstrated an exceptional track record of revenue and net income growth, driven by its performance-based consulting and proprietary technology platforms. However, this growth has been accompanied by significant cash flow volatility and recent margin compression.
  • Key risks include a high dependency on a few key industries, particularly finance and wellness, increasing competition, and the challenge of maintaining profitability while scaling. The recent negative operating cash flow is a primary concern for investors.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025

By αSK

  • Northwest Biotherapeutics is a clinical-stage biotechnology company whose value is almost entirely dependent on the regulatory approval and commercial success of its lead product candidate, DCVax-L, for glioblastoma (GBM), an aggressive form of brain cancer.
  • The company has completed a Phase III trial for DCVax-L, which it reported met its primary and secondary endpoints for extending survival in both newly diagnosed and recurrent GBM patients. A Marketing Authorization Application (MAA) was submitted to the UK’s MHRA in December 2023, making the regulatory decision a critical near-term catalyst.
  • Financially, the company is in a precarious position, characterized by a history of significant net losses, consistent cash burn, and a reliance on dilutive financing to fund operations. Future capital raises are a near certainty, posing a significant risk to current shareholders.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


USG 1:1 Rule on Semi Manufacturing: Not a Clear Positive to Intel but Clearly Positive to TSMC

By Nicolas Baratte

  • USG 1:1 domestic / import ratio for semi manufacturing not a clear positive for Intel. Intel needs a 14A node very quickly. But it’s positive to TSMC, increase pricing power.
  • The 1:1 rule is potentially positive for Intel and Samsung but only if they fix yield problems and offer complete design and IP tools to their customers. Long road ahead.
  • TSMC could increase US Capex and lower Taiwan Capex. But TSMC plans to make 30% of its advanced chips in the US from 2027. Capex increase would be mild.

Long Woodside (WDS AU), Short Ampol (ALD AU): Statistical Spread Hits Trigger in Aussie Energy Pair

By Gaudenz Schneider

  • Context: The Woodside Energy Group Ltd (WDS AU) vs. Ampol (ALD AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Woodside Energy (WDS AU) and short Ampol (ALD AU) targets a 6% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025

By Douglas Kim

  • In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 4Q 2025.
  • This was a STRONG REVERSAL of the relative share price performances of these 38 pairs in 3Q 2025 versus in 2Q 2025.
  • We provide four holdco/opco pairs that have experienced noticeable divergence in the past three months and we expect closing of their gaps could occur in the next several weeks

Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?

By Baptista Research

  • Occidental Petroleum Corporation is on the verge of its largest-ever divestment: the sale of its OxyChem petrochemical unit, in a deal that could fetch at least $10 billion.
  • According to recent reports, the company is deep in discussions, though no buyer has been named yet.
  • If finalized, this move will mark a pivotal shift in Occidental’s corporate structure—transforming the Houston-based energy giant’s strategic outlook and positioning it as one of the leanest and most carbon-focused companies in the sector.

Long ICICI (ICICIBC IN), Short HDFC (HDFCB IN): Fresh Statistical Arbitrage Signal in Indian Banks

By Gaudenz Schneider

  • Context: The ICICI Bank (ICICIBC IN) vs. HDFC Bank (HDFCB IN) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: The combination of going long ICICI Bank (ICICIBC IN) and short HDFC Bank (HDFCB IN) has traded profitably in July and is now flagged again as a fresh opportunity.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Intel: Money Only Solves Half the Problem. The 1:1 Domestic-To-Import Ratio Not a Clear Positive

By Nicolas Baratte

  • US Government invests $9bn in Intel, Nvidia another $5bn, Softbank $2bn. This solves Intel’s most pressing problem: the risk of financial fragility
  • But neither USG, nor Nvidia have semi manufacturing expertise, so $-injections don’t solve Intel’s 2nd problem. Intel has to  demonstrate a very solid 14A in the next 12 months
  • USG 1:1 import: domestic rule is positive to GlobalFoundries that can get orders away from SMIC or UMC. Positive to Texas Instrument

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Rocket Lab USA , Northwest Biotherapeutics, Fermi, Occidental Petroleum, Intel Corp, Zevra Therapeutics , UP Fintech, Rogers Corp, Rollins Inc, Lockheed Martin and more

By | Daily Briefs, United States

In today’s briefing:

  • Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!
  • Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025
  • Fermi Inc. (FRMI): Investors Bid Up Future AI Infrastructure, Shares Close 55% Higher
  • Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?
  • Intel: Money Only Solves Half the Problem. The 1:1 Domestic-To-Import Ratio Not a Clear Positive
  • Zevra Therapeutics In M&A Spotlight As Collegium Walks Away—What’s Next?
  • Primer: UP Fintech (TIGR US) – Oct 2025
  • Rogers’ $15B Power Play: Nears Full MLSE Buyout
  • Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?
  • Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025


Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!

By Baptista Research

  • Rocket Lab has taken a significant strategic step toward becoming a fully vertically integrated space company with its intent to acquire a controlling stake in Mynaric AG, a German-based laser communications provider.
  • The deal, still subject to regulatory and restructuring approvals, comes on the heels of Rocket Lab’s Q2 2025 earnings, where the company reported $39.6 million in revenue and reiterated its commitment to expanding across the entire space value chain.
  • If completed, the acquisition will give Rocket Lab access to Mynaric’s production capabilities, intellectual property, and workforce of over 300 engineers.

Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025

By αSK

  • Northwest Biotherapeutics is a clinical-stage biotechnology company whose value is almost entirely dependent on the regulatory approval and commercial success of its lead product candidate, DCVax-L, for glioblastoma (GBM), an aggressive form of brain cancer.
  • The company has completed a Phase III trial for DCVax-L, which it reported met its primary and secondary endpoints for extending survival in both newly diagnosed and recurrent GBM patients. A Marketing Authorization Application (MAA) was submitted to the UK’s MHRA in December 2023, making the regulatory decision a critical near-term catalyst.
  • Financially, the company is in a precarious position, characterized by a history of significant net losses, consistent cash burn, and a reliance on dilutive financing to fund operations. Future capital raises are a near certainty, posing a significant risk to current shareholders.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Fermi Inc. (FRMI): Investors Bid Up Future AI Infrastructure, Shares Close 55% Higher

By IPO Boutique

  • The company priced 32.5 million shares at $21.00 and saw its shares open at $25.00, a 19% premium.
  • Investor demand was strong and stemmed from pre-IPO testing-the-waters meetings with more than 100 investors.
  • The strong momentum generated from the debut suggests that traders may continue to gravitate toward the name, creating the potential for sharp swings in the near term. 

Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?

By Baptista Research

  • Occidental Petroleum Corporation is on the verge of its largest-ever divestment: the sale of its OxyChem petrochemical unit, in a deal that could fetch at least $10 billion.
  • According to recent reports, the company is deep in discussions, though no buyer has been named yet.
  • If finalized, this move will mark a pivotal shift in Occidental’s corporate structure—transforming the Houston-based energy giant’s strategic outlook and positioning it as one of the leanest and most carbon-focused companies in the sector.

Intel: Money Only Solves Half the Problem. The 1:1 Domestic-To-Import Ratio Not a Clear Positive

By Nicolas Baratte

  • US Government invests $9bn in Intel, Nvidia another $5bn, Softbank $2bn. This solves Intel’s most pressing problem: the risk of financial fragility
  • But neither USG, nor Nvidia have semi manufacturing expertise, so $-injections don’t solve Intel’s 2nd problem. Intel has to  demonstrate a very solid 14A in the next 12 months
  • USG 1:1 import: domestic rule is positive to GlobalFoundries that can get orders away from SMIC or UMC. Positive to Texas Instrument

Zevra Therapeutics In M&A Spotlight As Collegium Walks Away—What’s Next?

By Baptista Research

  • Zevra Therapeutics has recently seen its stock jump following renewed takeover speculation, spotlighting the company’s strategic value in the rare disease therapeutics space.
  • The catalyst was a Betaville alert reporting that Collegium Pharmaceuticals had previously explored acquiring Zevra but failed to secure the necessary financing.
  • This is not the first time Zevra has attracted M&A interest—Betaville had flagged potential acquisition talks weeks earlier.

Primer: UP Fintech (TIGR US) – Oct 2025

By αSK

  • UP Fintech (TIGR US) is a high-growth online brokerage firm strategically focused on serving global Chinese investors. The company has demonstrated robust financial performance, with significant revenue and net income growth, driven by an expanding client base and increased trading volumes.
  • The company’s proprietary technology platform, ‘Tiger Trade,’ offers a seamless user experience for trading a wide array of financial instruments across international markets. This technological edge, combined with a ‘mobile-first’ strategy, is a key driver of customer acquisition and retention.
  • While expanding its global footprint, particularly in Singapore and Hong Kong, UP Fintech faces increasing competition and evolving regulatory landscapes in the fintech sector. Navigating these challenges will be crucial for sustaining its growth trajectory.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Rogers’ $15B Power Play: Nears Full MLSE Buyout

By Baptista Research

  • In a transformative move with far-reaching implications for Canada’s telecom and sports entertainment landscape, Rogers Communications is edging closer to acquiring full control of Maple Leaf Sports & Entertainment (MLSE), the multi-billion-dollar entity behind the Toronto Maple Leafs, Toronto Raptors, and Scotiabank Arena.
  • Having recently secured a 75% controlling stake by triggering a buyout clause for billionaire Larry Tanenbaum’s remaining 25% share, Rogers is now laying the groundwork for combining MLSE with its other marquee assets, including the Toronto Blue Jays and Sportsnet.
  • As this consolidation unfolds, CEO Tony Staffieri has confirmed that the company is actively exploring monetization strategies—either via an IPO or a private stake sale—to attract new equity investors.

Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?

By Baptista Research

  • Rollins Inc, the parent company of Orkin and other leading pest control brands, has emerged as one of the most resilient performers of 2025, gaining over 25% year-to-date.
  • While many businesses scramble to adapt to the rapid disruption of artificial intelligence, Rollins stands apart.
  • It’s not just surviving the AI wave—it’s thriving.

Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Lockheed Martin is considered a strong investment due to geopolitical tensions and increased defense spending.
  • The company has four main divisions, including Aeronautics and Missiles and Fire Control, focusing on advanced military technology.
  • Lockheed Martin’s diverse portfolio positions it for growth in the defense sector amid current global security challenges.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Mitsubishi Logisnext Co., Ltd., Rocket Lab USA , Samsung C&T, ST Engineering, Rollins Inc, Lockheed Martin, Credit Bureau Asia, Huationg Global, ICTSI, Rich Sparkle Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad
  • Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025
  • Primer: ST Engineering (STE SP) – Oct 2025
  • Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?
  • Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025
  • Primer: Credit Bureau Asia (CBA SP) – Oct 2025
  • Primer: Huationg Global (HUAGL SP) – Oct 2025
  • Primer: ICTSI (ICT PM) – Oct 2025
  • The Equity Dispatch #51 : Another Chinese Promote


[Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad

By Travis Lundy

  • JIP and MitHeavy have announced a takeunder to buy out MitHeavy sub Mitsubishi Logisnext Co., Ltd. (7105 JP) at a weighted average price 42% lower than Target Advisor DCF range midpoint.
  • No/Minimal transparency. A sales process interrupted by Trump tariffs, leaving one low-ball bidder. And the sellers goes ahead with it BUT gets to reinvest on the back end. You don’t.
  • The Board “supports” the Tender Offer, but leaves it to the opinion of the shareholders as to whether they tender. MitHeavy has 64.4% already so that basically gets done. But…

Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!

By Baptista Research

  • Rocket Lab has taken a significant strategic step toward becoming a fully vertically integrated space company with its intent to acquire a controlling stake in Mynaric AG, a German-based laser communications provider.
  • The deal, still subject to regulatory and restructuring approvals, comes on the heels of Rocket Lab’s Q2 2025 earnings, where the company reported $39.6 million in revenue and reiterated its commitment to expanding across the entire space value chain.
  • If completed, the acquisition will give Rocket Lab access to Mynaric’s production capabilities, intellectual property, and workforce of over 300 engineers.

Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025

By Douglas Kim

  • In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 4Q 2025.
  • This was a STRONG REVERSAL of the relative share price performances of these 38 pairs in 3Q 2025 versus in 2Q 2025.
  • We provide four holdco/opco pairs that have experienced noticeable divergence in the past three months and we expect closing of their gaps could occur in the next several weeks

Primer: ST Engineering (STE SP) – Oct 2025

By αSK

  • ST Engineering‘s growth is underpinned by a record-high order book, fueled by strong demand in its Commercial Aerospace and Defence & Public Security segments, which are benefiting from the global recovery in air travel and increased military spending.
  • The company is a global leader in aircraft Maintenance, Repair, and Overhaul (MRO) and is strategically expanding its capabilities in smart city solutions and defence technology, including AI-driven systems and unmanned vehicles.
  • While operational performance is strong, valuation appears stretched. The Urban Solutions & Satcom segment, particularly the satellite communications (SATCOM) business, has faced headwinds from supply chain disruptions and restructuring costs, acting as a drag on overall profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?

By Baptista Research

  • Rollins Inc, the parent company of Orkin and other leading pest control brands, has emerged as one of the most resilient performers of 2025, gaining over 25% year-to-date.
  • While many businesses scramble to adapt to the rapid disruption of artificial intelligence, Rollins stands apart.
  • It’s not just surviving the AI wave—it’s thriving.

Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Lockheed Martin is considered a strong investment due to geopolitical tensions and increased defense spending.
  • The company has four main divisions, including Aeronautics and Missiles and Fire Control, focusing on advanced military technology.
  • Lockheed Martin’s diverse portfolio positions it for growth in the defense sector amid current global security challenges.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Credit Bureau Asia (CBA SP) – Oct 2025

By αSK

  • Dominant Market Position with High Barriers to Entry: Credit Bureau Asia (CBA) holds a near-monopolistic position in Singapore’s Financial Institution (FI) data business with an estimated 99.9% market share. It is also the sole credit bureau in Cambodia and Myanmar, creating significant barriers to entry for potential competitors.
  • Resilient and Cash-Generative Business Model: The company’s business model is resilient across economic cycles, benefiting from increased demand for credit risk assessment during both economic expansions and downturns. CBA is highly cash-generative with minimal capital expenditure requirements, supporting a consistent dividend payout.
  • Multiple Growth Levers: Growth is expected to be driven by the expansion of digital banking in Singapore, increasing credit penetration in emerging markets like Cambodia and Myanmar, and the growth of its Non-Financial Institution (Non-FI) data business through new product offerings and regional expansion.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Huationg Global (HUAGL SP) – Oct 2025

By αSK

  • Huationg Global is a well-established civil engineering firm in Singapore, poised to benefit from a robust public infrastructure spending pipeline, including major projects like the Changi Airport Terminal 5 and various MRT lines.
  • The company has demonstrated a strong growth trajectory, with a 3-year net income compound annual growth rate (CAGR) of 45.35% and operating cash flow CAGR of 65.09%, indicating efficient execution and strong project management.
  • Valuation appears attractive, with a very low P/E ratio and a strong net cash position. The company also offers a compelling dividend yield, which has been consistently high over the past three years.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: ICTSI (ICT PM) – Oct 2025

By αSK

  • ICTSI is a leading global, independent container terminal operator with a geographically diverse portfolio across Asia, the Americas, Europe, the Middle East, and Africa, positioning it to capitalize on global trade flows.
  • The company has demonstrated a strong growth track record, with double-digit compound annual growth rates in revenue, net income, and dividends over the past decade, driven by both organic expansion and strategic acquisitions.
  • Future growth is expected to be supported by tariff hikes at key terminals, continued strategic capacity expansion in high-growth emerging markets, and a focus on operational efficiency, though risks from global economic slowdowns and geopolitical tensions remain.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


The Equity Dispatch #51 : Another Chinese Promote

By J Capital Research

  • Rich Sparkle is an absurd, Hong Kong based financial printing company whose share-price rise can only be attributed to the thin float—about 10% of the company.
  • That means that, if the 90% of under-the-surface owners chose to buy at prices higher than the company merits, a few purchases would drive up the price of the whole company.
  • We do not know whether this stock is manipulated, but there is nothing we can identify in the fundamentals or the sector it operates in that would make ANPA an attractive company to own at its current valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: ST Engineering, Centurion Corp, Credit Bureau Asia, Huationg Global, Moneymax Financial Services and more

By | Daily Briefs, Singapore

In today’s briefing:

  • Primer: ST Engineering (STE SP) – Oct 2025
  • Primer: Centurion Corp (CENT SP) – Oct 2025
  • Primer: Credit Bureau Asia (CBA SP) – Oct 2025
  • Primer: Huationg Global (HUAGL SP) – Oct 2025
  • kopi-C with MoneyMax Financial Services Ltd – How MoneyMax is taking the pawnbroking industry into the future


Primer: ST Engineering (STE SP) – Oct 2025

By αSK

  • ST Engineering‘s growth is underpinned by a record-high order book, fueled by strong demand in its Commercial Aerospace and Defence & Public Security segments, which are benefiting from the global recovery in air travel and increased military spending.
  • The company is a global leader in aircraft Maintenance, Repair, and Overhaul (MRO) and is strategically expanding its capabilities in smart city solutions and defence technology, including AI-driven systems and unmanned vehicles.
  • While operational performance is strong, valuation appears stretched. The Urban Solutions & Satcom segment, particularly the satellite communications (SATCOM) business, has faced headwinds from supply chain disruptions and restructuring costs, acting as a drag on overall profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Centurion Corp (CENT SP) – Oct 2025

By αSK

  • Centurion Corp is a leading owner-operator of specialized accommodation, focusing on Purpose-Built Worker Accommodation (PBWA) in Singapore and Malaysia, and Purpose-Built Student Accommodation (PBSA) in the UK, Australia, and other markets.
  • The company is poised for growth, driven by strong secular tailwinds in both its core segments, including regulatory pushes for higher quality worker dormitories and a persistent demand-supply imbalance in student housing in key educational hubs.
  • A key strategic initiative is the planned spin-off of a portfolio of its stabilized assets into a REIT, which is expected to unlock significant value, transition the company towards an asset-light model, and enhance shareholder returns through capital recycling and potential special dividends.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Credit Bureau Asia (CBA SP) – Oct 2025

By αSK

  • Dominant Market Position with High Barriers to Entry: Credit Bureau Asia (CBA) holds a near-monopolistic position in Singapore’s Financial Institution (FI) data business with an estimated 99.9% market share. It is also the sole credit bureau in Cambodia and Myanmar, creating significant barriers to entry for potential competitors.
  • Resilient and Cash-Generative Business Model: The company’s business model is resilient across economic cycles, benefiting from increased demand for credit risk assessment during both economic expansions and downturns. CBA is highly cash-generative with minimal capital expenditure requirements, supporting a consistent dividend payout.
  • Multiple Growth Levers: Growth is expected to be driven by the expansion of digital banking in Singapore, increasing credit penetration in emerging markets like Cambodia and Myanmar, and the growth of its Non-Financial Institution (Non-FI) data business through new product offerings and regional expansion.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Huationg Global (HUAGL SP) – Oct 2025

By αSK

  • Huationg Global is a well-established civil engineering firm in Singapore, poised to benefit from a robust public infrastructure spending pipeline, including major projects like the Changi Airport Terminal 5 and various MRT lines.
  • The company has demonstrated a strong growth trajectory, with a 3-year net income compound annual growth rate (CAGR) of 45.35% and operating cash flow CAGR of 65.09%, indicating efficient execution and strong project management.
  • Valuation appears attractive, with a very low P/E ratio and a strong net cash position. The company also offers a compelling dividend yield, which has been consistently high over the past three years.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


kopi-C with MoneyMax Financial Services Ltd – How MoneyMax is taking the pawnbroking industry into the future

By Geoff Howie

  • MoneyMax’s group revenue rose 31.2% year-on-year to S$243.0 million, with net profits increasing 76.4% to S$31.8 million in H1 FY2025.
  • The company’s five-year plan includes expanding in Singapore and Malaysia and exploring Southeast Asian markets with similar demographics.
  • MoneyMax maintains a robust balance sheet, holding cash and cash equivalents of approximately S$18.9 million as of 30 June 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Industrials: Mitsubishi Logisnext Co., Ltd., Rocket Lab USA , Samsung C&T, ST Engineering, Rollins Inc, Lockheed Martin, Credit Bureau Asia, Huationg Global, ICTSI, Rich Sparkle Holdings and more

By | Daily Briefs, Industrials

In today’s briefing:

  • [Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad
  • Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025
  • Primer: ST Engineering (STE SP) – Oct 2025
  • Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?
  • Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025
  • Primer: Credit Bureau Asia (CBA SP) – Oct 2025
  • Primer: Huationg Global (HUAGL SP) – Oct 2025
  • Primer: ICTSI (ICT PM) – Oct 2025
  • The Equity Dispatch #51 : Another Chinese Promote


[Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad

By Travis Lundy

  • JIP and MitHeavy have announced a takeunder to buy out MitHeavy sub Mitsubishi Logisnext Co., Ltd. (7105 JP) at a weighted average price 42% lower than Target Advisor DCF range midpoint.
  • No/Minimal transparency. A sales process interrupted by Trump tariffs, leaving one low-ball bidder. And the sellers goes ahead with it BUT gets to reinvest on the back end. You don’t.
  • The Board “supports” the Tender Offer, but leaves it to the opinion of the shareholders as to whether they tender. MitHeavy has 64.4% already so that basically gets done. But…

Rocket Lab Corp’s Mynaric Bid Could Upend The Satellite Industry!

By Baptista Research

  • Rocket Lab has taken a significant strategic step toward becoming a fully vertically integrated space company with its intent to acquire a controlling stake in Mynaric AG, a German-based laser communications provider.
  • The deal, still subject to regulatory and restructuring approvals, comes on the heels of Rocket Lab’s Q2 2025 earnings, where the company reported $39.6 million in revenue and reiterated its commitment to expanding across the entire space value chain.
  • If completed, the acquisition will give Rocket Lab access to Mynaric’s production capabilities, intellectual property, and workforce of over 300 engineers.

Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025

By Douglas Kim

  • In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 4Q 2025.
  • This was a STRONG REVERSAL of the relative share price performances of these 38 pairs in 3Q 2025 versus in 2Q 2025.
  • We provide four holdco/opco pairs that have experienced noticeable divergence in the past three months and we expect closing of their gaps could occur in the next several weeks

Primer: ST Engineering (STE SP) – Oct 2025

By αSK

  • ST Engineering‘s growth is underpinned by a record-high order book, fueled by strong demand in its Commercial Aerospace and Defence & Public Security segments, which are benefiting from the global recovery in air travel and increased military spending.
  • The company is a global leader in aircraft Maintenance, Repair, and Overhaul (MRO) and is strategically expanding its capabilities in smart city solutions and defence technology, including AI-driven systems and unmanned vehicles.
  • While operational performance is strong, valuation appears stretched. The Urban Solutions & Satcom segment, particularly the satellite communications (SATCOM) business, has faced headwinds from supply chain disruptions and restructuring costs, acting as a drag on overall profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Rollins Has An AI-Proof Moat—But Is The Stock Too Pricey?

By Baptista Research

  • Rollins Inc, the parent company of Orkin and other leading pest control brands, has emerged as one of the most resilient performers of 2025, gaining over 25% year-to-date.
  • While many businesses scramble to adapt to the rapid disruption of artificial intelligence, Rollins stands apart.
  • It’s not just surviving the AI wave—it’s thriving.

Lockheed Martin Corp (LMT) – Wednesday, Jul 2, 2025

By Value Investors Club (VIC)

Key points (machine generated)

  • Lockheed Martin is considered a strong investment due to geopolitical tensions and increased defense spending.
  • The company has four main divisions, including Aeronautics and Missiles and Fire Control, focusing on advanced military technology.
  • Lockheed Martin’s diverse portfolio positions it for growth in the defense sector amid current global security challenges.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Primer: Credit Bureau Asia (CBA SP) – Oct 2025

By αSK

  • Dominant Market Position with High Barriers to Entry: Credit Bureau Asia (CBA) holds a near-monopolistic position in Singapore’s Financial Institution (FI) data business with an estimated 99.9% market share. It is also the sole credit bureau in Cambodia and Myanmar, creating significant barriers to entry for potential competitors.
  • Resilient and Cash-Generative Business Model: The company’s business model is resilient across economic cycles, benefiting from increased demand for credit risk assessment during both economic expansions and downturns. CBA is highly cash-generative with minimal capital expenditure requirements, supporting a consistent dividend payout.
  • Multiple Growth Levers: Growth is expected to be driven by the expansion of digital banking in Singapore, increasing credit penetration in emerging markets like Cambodia and Myanmar, and the growth of its Non-Financial Institution (Non-FI) data business through new product offerings and regional expansion.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: Huationg Global (HUAGL SP) – Oct 2025

By αSK

  • Huationg Global is a well-established civil engineering firm in Singapore, poised to benefit from a robust public infrastructure spending pipeline, including major projects like the Changi Airport Terminal 5 and various MRT lines.
  • The company has demonstrated a strong growth trajectory, with a 3-year net income compound annual growth rate (CAGR) of 45.35% and operating cash flow CAGR of 65.09%, indicating efficient execution and strong project management.
  • Valuation appears attractive, with a very low P/E ratio and a strong net cash position. The company also offers a compelling dividend yield, which has been consistently high over the past three years.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Primer: ICTSI (ICT PM) – Oct 2025

By αSK

  • ICTSI is a leading global, independent container terminal operator with a geographically diverse portfolio across Asia, the Americas, Europe, the Middle East, and Africa, positioning it to capitalize on global trade flows.
  • The company has demonstrated a strong growth track record, with double-digit compound annual growth rates in revenue, net income, and dividends over the past decade, driven by both organic expansion and strategic acquisitions.
  • Future growth is expected to be supported by tariff hikes at key terminals, continued strategic capacity expansion in high-growth emerging markets, and a focus on operational efficiency, though risks from global economic slowdowns and geopolitical tensions remain.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


The Equity Dispatch #51 : Another Chinese Promote

By J Capital Research

  • Rich Sparkle is an absurd, Hong Kong based financial printing company whose share-price rise can only be attributed to the thin float—about 10% of the company.
  • That means that, if the 90% of under-the-surface owners chose to buy at prices higher than the company merits, a few purchases would drive up the price of the whole company.
  • We do not know whether this stock is manipulated, but there is nothing we can identify in the fundamentals or the sector it operates in that would make ANPA an attractive company to own at its current valuation.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: LG Chem , Samsung C&T and more

By | Daily Briefs, South Korea

In today’s briefing:

  • LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset
  • Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025


LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset

By Douglas Kim

  • LG Chem announced that it plans to complete a price return swap worth about 2 trillion won (US$1.4 billion) using its stake in LG Energy Solution as the base asset.
  • This 2 trillion won PRS is likely to have a slightly positive impact on LG Chem and slightly negative impact on LG Energy Solution.
  • Our NAV valuation of LG Chem suggests implied NAV per share of 369,187 won, which is 31% higher than current levels.

Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2025

By Douglas Kim

  • In this insight, we highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in 4Q 2025.
  • This was a STRONG REVERSAL of the relative share price performances of these 38 pairs in 3Q 2025 versus in 2Q 2025.
  • We provide four holdco/opco pairs that have experienced noticeable divergence in the past three months and we expect closing of their gaps could occur in the next several weeks

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Northwest Biotherapeutics, Zevra Therapeutics , Lee’s Pharmaceutical, Innovent Biologics Inc, Genmab A/S, VolitionRX , IMPACT Therapeutics and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025
  • Zevra Therapeutics In M&A Spotlight As Collegium Walks Away—What’s Next?
  • Primer: Lee’s Pharmaceutical (950 HK) – Oct 2025
  • Innovent Biologics Inc (1801 HK): Dual Engine Growth Strategy Is Yielding Result
  • GMAB’s $5B Power Play: Is Merus The Missing Piece In Its Cancer War Chest?
  • VNRX: During September
  • Impact Therapeutics (英派药业) Pre-IPO: Credible R&D in PARP


Primer: Northwest Biotherapeutics (NWBO US) – Oct 2025

By αSK

  • Northwest Biotherapeutics is a clinical-stage biotechnology company whose value is almost entirely dependent on the regulatory approval and commercial success of its lead product candidate, DCVax-L, for glioblastoma (GBM), an aggressive form of brain cancer.
  • The company has completed a Phase III trial for DCVax-L, which it reported met its primary and secondary endpoints for extending survival in both newly diagnosed and recurrent GBM patients. A Marketing Authorization Application (MAA) was submitted to the UK’s MHRA in December 2023, making the regulatory decision a critical near-term catalyst.
  • Financially, the company is in a precarious position, characterized by a history of significant net losses, consistent cash burn, and a reliance on dilutive financing to fund operations. Future capital raises are a near certainty, posing a significant risk to current shareholders.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Zevra Therapeutics In M&A Spotlight As Collegium Walks Away—What’s Next?

By Baptista Research

  • Zevra Therapeutics has recently seen its stock jump following renewed takeover speculation, spotlighting the company’s strategic value in the rare disease therapeutics space.
  • The catalyst was a Betaville alert reporting that Collegium Pharmaceuticals had previously explored acquiring Zevra but failed to secure the necessary financing.
  • This is not the first time Zevra has attracted M&A interest—Betaville had flagged potential acquisition talks weeks earlier.

Primer: Lee’s Pharmaceutical (950 HK) – Oct 2025

By αSK

  • Lee’s Pharmaceutical is an integrated biopharmaceutical company focused on the Chinese market, with a dual strategy of developing proprietary drugs and licensing international products.
  • The company demonstrated a significant financial turnaround in the most recent fiscal year, with substantial growth in revenue and net income, reversing a trend of long-term decline.
  • Despite a recent recovery, the company faces high uncertainty due to a history of volatile earnings and significant long-term declines in key metrics like net income and market capitalization, balanced against a currently attractive valuation.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.


Innovent Biologics Inc (1801 HK): Dual Engine Growth Strategy Is Yielding Result

By Tina Banerjee

  • Innovent Biologics Inc (1801 HK) has announced 1H25 result, with total revenue increasing 51% YoY. The company recorded its maiden net profit of RMB834M on a reported basis.
  • Despite an overcrowded PD-1 inhibitor market in China, core oncology product, Tyvyt maintained good growth momentum. Tyvyt is under NDA review for its ninth and tenth indications.
  • In June, Innovent received approval for mazdutide, first-in-class chronic weight management drug in China. In 2H25, mazdutide is expected to receive approval for a second indication in type 2 diabetes.

GMAB’s $5B Power Play: Is Merus The Missing Piece In Its Cancer War Chest?

By Baptista Research

  • In a rapidly evolving biotech landscape, Danish cancer therapeutics giant Genmab is reportedly in advanced talks to acquire Merus N.V., a Dutch developer specializing in bispecific antibodies for hard-to-treat cancers like head and neck tumors.
  • This potential deal, tipped to be announced imminently, follows a mid-stage clinical win for Merus’s lead asset, petosemtamab, which showed an impressive 63% overall response rate when combined with Merck’s Keytruda.
  • With Merus’s market capitalization surging over 60% YTD to $5.2 billion, Genmab appears to be positioning itself for a strategic leap in the immuno-oncology arena.

VNRX: During September

By Zacks Small Cap Research

  • Primary operational goal for 2025 is to enter into multiple licensing agreements for human diagnostic applications, e.g. cancer & sepsis.
  • In September, two (2) licensing agreements were signed: one with Werfen S.A. for Nu.Q NETs research and the other with Hologic for Nu.Q Discover services.
  • Within the Nu.Q NETs pillar, the commercial strategy to utilize the CE Mark has brought on 11 hospital networks in Europe thus far in 2025.

Impact Therapeutics (英派药业) Pre-IPO: Credible R&D in PARP

By Ke Yan, CFA, FRM

  • Impact Therapeutics, a China-based near-commercial-stage biopharma company, is looking to raise at least USD 100 million via a Hong Kong listing. GS and CICC are the joint sponsors
  • In this note, we look at the company’s core products, senaparib/IMP4297, and key products IMP1734 and IMP9064.
  • We also look at the company’s pre-IPO investors and management team.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: [Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • [Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad
  • LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset
  • GST Exemption: A Catalyst for Growth and Margin Headwinds for ICICI Prudential Life
  • RateGain Acquisition of Sojern: A Travel Tech Powerhouse in the Making?
  • Selected European HoldCos and DLC: September 2025 Report


[Japan M&A] Mitsubishi Logisnext (7105) – This Deal Looks Mighty Bad

By Travis Lundy

  • JIP and MitHeavy have announced a takeunder to buy out MitHeavy sub Mitsubishi Logisnext Co., Ltd. (7105 JP) at a weighted average price 42% lower than Target Advisor DCF range midpoint.
  • No/Minimal transparency. A sales process interrupted by Trump tariffs, leaving one low-ball bidder. And the sellers goes ahead with it BUT gets to reinvest on the back end. You don’t.
  • The Board “supports” the Tender Offer, but leaves it to the opinion of the shareholders as to whether they tender. MitHeavy has 64.4% already so that basically gets done. But…

LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset

By Douglas Kim

  • LG Chem announced that it plans to complete a price return swap worth about 2 trillion won (US$1.4 billion) using its stake in LG Energy Solution as the base asset.
  • This 2 trillion won PRS is likely to have a slightly positive impact on LG Chem and slightly negative impact on LG Energy Solution.
  • Our NAV valuation of LG Chem suggests implied NAV per share of 369,187 won, which is 31% higher than current levels.

GST Exemption: A Catalyst for Growth and Margin Headwinds for ICICI Prudential Life

By Nimish Maheshwari

  • The GST Council’s decision to exempt all individual life and health insurance premiums from GST (0% vs. 18% earlier), effective September 22, 2025, is a landmark affordability move.
  • The immediate drop in premiums for products like term and ULIPs is expected to drive a significant surge in demand, though insurers like ICICI Prudential will lose ITC on expenses.
  • While the volume boost from higher affordability is a major long-term catalyst,  immediate margin compression from ITC loss on commissions will require operational efficiency and pricing recalibration for ICICI Prudential.

RateGain Acquisition of Sojern: A Travel Tech Powerhouse in the Making?

By Nimish Maheshwari

  • RateGain Travel Technologies has entered into a definitive agreement to acquire US-based, AI-powered travel marketing platform Sojern for an upfront consideration of $250 million.
  • The acquisition is a bold move to create a scaled, AI-first digital marketing and distribution platform, significantly boosting RateGain’s MarTech business and nearly tripling its revenue/EBITDA run-rate (pre-synergies).
  • The strategic upside of owning the full guest acquisition-to-retention cycle justifies the blended financing structure and the integration risk of two large, geographically dispersed travel tech companies.

Selected European HoldCos and DLC: September 2025 Report

By Jesus Rodriguez Aguilar

  • Holdco discounts tightened in September: GBL to 28.1%, Industrivärden C to 6.9%, Investor B to 10.9%, Heineken Holding to 12.1%; Porsche SE widened to 31.6%; Rio Tinto DLC premium 21.6%.
  • Drivers: discounts compress with buybacks and bull markets. GBL cancelling repurchases; target sub-25% discount. Heineken Holding’s control structure sustains a spread. Swedish holdcos are investment-grade, high-quality, with low look-through discounts.
  • Catalysts: Vivendi’s AMF-driven mandatory-offer path, appeals pending, base-case €4.15 bid. Rio Tinto DLC unification could unlock $27–32B despite May vote. Porsche SE discount reflects deleveraging priority; legal overhang increasingly immaterial.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Energy/Materials: LG Chem , Woodside Energy Group Ltd, Fermi, Occidental Petroleum, Arrow Exploration Corp, Rayonier Advanced Materials, Crude Oil, Zephyr Energy, Capitan Silver , Directa Plus and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset
  • Long Woodside (WDS AU), Short Ampol (ALD AU): Statistical Spread Hits Trigger in Aussie Energy Pair
  • Fermi Inc. (FRMI): Investors Bid Up Future AI Infrastructure, Shares Close 55% Higher
  • Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?
  • Arrow Exploration Corp. (AIM: AXL): Dry Hole at Mateguafa Oeste but Three More Prospects to Drill
  • Rayonier Advanced Materials, Inc.: Having Weathered 1H25 Crosswinds…
  • Oil futures: Crude retreats on mixed signalling from OPEC+
  • Zephyr Energy Plc (AIM: ZPHR): All eyes on upcoming CPR for the Paradox
  • CAPT: Early Exploration on Acquired Land Shows Significant Promise
  • Hybridan Small Cap Feast: 24/09/2025


LG Chem: Announces a PRS Worth 2 Trillion Won Using Its Shares in LG Energy Solution as Base Asset

By Douglas Kim

  • LG Chem announced that it plans to complete a price return swap worth about 2 trillion won (US$1.4 billion) using its stake in LG Energy Solution as the base asset.
  • This 2 trillion won PRS is likely to have a slightly positive impact on LG Chem and slightly negative impact on LG Energy Solution.
  • Our NAV valuation of LG Chem suggests implied NAV per share of 369,187 won, which is 31% higher than current levels.

Long Woodside (WDS AU), Short Ampol (ALD AU): Statistical Spread Hits Trigger in Aussie Energy Pair

By Gaudenz Schneider

  • Context: The Woodside Energy Group Ltd (WDS AU) vs. Ampol (ALD AU) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Woodside Energy (WDS AU) and short Ampol (ALD AU) targets a 6% return.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Fermi Inc. (FRMI): Investors Bid Up Future AI Infrastructure, Shares Close 55% Higher

By IPO Boutique

  • The company priced 32.5 million shares at $21.00 and saw its shares open at $25.00, a 19% premium.
  • Investor demand was strong and stemmed from pre-IPO testing-the-waters meetings with more than 100 investors.
  • The strong momentum generated from the debut suggests that traders may continue to gravitate toward the name, creating the potential for sharp swings in the near term. 

Occidental’s $10 Billion Oxychem Deal Could Reshape Its Future — But No Buyer In Sight?

By Baptista Research

  • Occidental Petroleum Corporation is on the verge of its largest-ever divestment: the sale of its OxyChem petrochemical unit, in a deal that could fetch at least $10 billion.
  • According to recent reports, the company is deep in discussions, though no buyer has been named yet.
  • If finalized, this move will mark a pivotal shift in Occidental’s corporate structure—transforming the Houston-based energy giant’s strategic outlook and positioning it as one of the leanest and most carbon-focused companies in the sector.

Arrow Exploration Corp. (AIM: AXL): Dry Hole at Mateguafa Oeste but Three More Prospects to Drill

By Auctus Advisors

  • The Mateguafa Oeste was water wet. Our ReNAV for the well was £0.09 per share.
  • We did not carry any production from this prospect in our cash flow forecast.
  • The rig will now move to Mateguafa Attic where the Mateguafa 5 vertical well will be drilled in November. 

Rayonier Advanced Materials, Inc.: Having Weathered 1H25 Crosswinds…

By Water Tower Research

  • 2H25 EBITDA guidance reflective of more normalized performance.
  • While non-recurring headwinds, such as tariff- related order pattern disruptions, operational challenges, labor strikes, and adverse weather, reduced 1H25 EBITDA by close to $60 million, 2H25 EBITDA guidance of $105-115 million implies a return to more normal operations and profitability levels as RYAM works to improve costs and drive higher volumes and prices.
  • Robust pipeline of cost saving and efficiency projects. RYAM has launched a targeted capital deployment of $24 million to drive $30 million in annual cost savings in its core cellulose specialties (CS) business in 2026, with additional projects envisioned for 2027 and beyond, as the company continues to optimize its operations and streamline costs, positioning itself to fully benefit from the market recovery and take advantage of incremental growth opportunities.

Oil futures: Crude retreats on mixed signalling from OPEC+

By Quantum Commodity Intelligence

  • Quantum Commodity Intelligence – Crude oil futures were drifting lower Wednesday, extending the heavy losses in the early part of the week amid growing concerns that markets could face a significant supply glut in Q4.
  • Front-month Dec25 ICE Brent  futures were trading at  $65.54/b (2000 BST) versus Tuesday’s settle of $66.03/b, while Nov25 NYMEX WTI  was at  $61.97/b against a previous close of $62.37/b.
  • Benchmarks came under pressure after Bloomberg reported on Tuesday that OPEC+ is considering an accelerated schedule on unwinding a second tranche of production cuts, which could fast-track the return of around 1.5 million bpd in just three months.

Zephyr Energy Plc (AIM: ZPHR): All eyes on upcoming CPR for the Paradox

By Auctus Advisors

  • 2Q25 sales (excluding NGLs) averaged 632 boe/d, reflecting continued operator-imposed constraints on the six Slawson wells due to prevailing low commodity prices.
  • Aggregate production from these wells in 1H25 was 141 boe/d, below management’s forecast of 214 boe/d.
  • Importantly, there are no reservoir integrity concerns.

CAPT: Early Exploration on Acquired Land Shows Significant Promise

By Atrium Research

  • Capitan announced mapping, trenching, and soil sampling results as part of a reconnaissance-scale program on the newly acquired land package.
  • Early work shows strong silver and gold mineralization on the north side of the granodiorite intrusion, significantly expanding the size potential.
  • CAPT has upsized its fully funded Phase 1 program by 50% to 15,000m; ~8,000m drilled to date with 38 RC assays pending.

Hybridan Small Cap Feast: 24/09/2025

By Hybridan

  • 8th September: Project Glow Topco Limited, the ultimate holding Company of The Beauty Tech Group Limited, a global leader in the rapidly growing at-home beauty technology market, encompasses three distinct, innovative and premium beauty technology brands – CurrentBody Skin, ZIIP Beauty and Tria Laser – under which it develops, manufactures and retails at-home beauty devices.
  • In FY24, the Group reported revenue of £101.1m and adjusted EBITDA of £22.9m.
  • Between the financial period for the 16 months ended 31 January 2023 (FY22) and FY24, the Group’s own-brand revenue and adjusted EBITDA grew at a compound annual growth rate of 73.6% and 92.9% respectively. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: EA: Core Excess Revealed In Sep-25 and more

By | Daily Briefs, Macro

In today’s briefing:

  • EA: Core Excess Revealed In Sep-25
  • HONG KONG ALPHA PORTFOLIO: (September 2025)
  • Colombia Holds Rates at 9.25% Amid Inflation Persistence
  • Exencial Economy Tidings 01/10/2025
  • Oil futures: Crude retreats on mixed signalling from OPEC+
  • RBI Holds Rates Amid Trade Headwinds
  • Slogans, Propaganda or Actions?


EA: Core Excess Revealed In Sep-25

By Phil Rush

  • Inflation’s break above target to 2.23%, within 1bp of our forecast, came as past energy price falls dropped out to reveal the more resilient underlying pressures.
  • Small upside surprises in large countries, like Germany and Italy, were balanced in number and contribution by larger surprises in small ones, like Greece and Estonia.
  • We expect less negative payback in October and January, preventing our profile from languishing below the target through 2026, like the consensus view does.

HONG KONG ALPHA PORTFOLIO: (September 2025)

By David Mudd

  • Hong Kong Alpha portfolio gained 8.45% in September and 60.89% and 62.80% YTD and since launch one year ago.  The portfolio has outperformed Hong Kong indexes by more than 40%.
  • The portfolio has a Sharpe ratio of 3.23 YTD and has generated more than 40% of its returns from stock-picking (alpha).  Its beta is low at only 1.17.
  • At the end of September, we increased exposure to AI and robotics and sold positions in the consumer and finance sectors.

Colombia Holds Rates at 9.25% Amid Inflation Persistence

By Heteronomics AI

  • The central bank held rates at 9.25% in a 4-3 split vote, matching consensus expectations but extending the pause cycle to four months amid 5.1% inflation.
  • Slower inflation convergence toward 3% target drives caution as service prices remain sticky and analyst expectations rise to 5% for 2025.
  • Fiscal deficit widening to 7.1% of GDP and rule suspension through 2027 limits monetary policy flexibility and prolongs the restrictive stance.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Exencial Economy Tidings 01/10/2025

By Viral Kishorchandra Shah

  • Bankers Optimistic on Loan Demand and Terms: RBI Lending Survey
  • Capacity utilisation declines to 74.1% in Q1FY26: RBI OBICUS survey
  • New project announcements fall to Rs.5.2 trillion in September 2025 quarter

Oil futures: Crude retreats on mixed signalling from OPEC+

By Quantum Commodity Intelligence

  • Quantum Commodity Intelligence – Crude oil futures were drifting lower Wednesday, extending the heavy losses in the early part of the week amid growing concerns that markets could face a significant supply glut in Q4.
  • Front-month Dec25 ICE Brent  futures were trading at  $65.54/b (2000 BST) versus Tuesday’s settle of $66.03/b, while Nov25 NYMEX WTI  was at  $61.97/b against a previous close of $62.37/b.
  • Benchmarks came under pressure after Bloomberg reported on Tuesday that OPEC+ is considering an accelerated schedule on unwinding a second tranche of production cuts, which could fast-track the return of around 1.5 million bpd in just three months.

RBI Holds Rates Amid Trade Headwinds

By Heteronomics AI

  • The RBI held its repo rate at 5.5%, unanimously keeping a neutral stance as the committee assesses the impact of prior cuts amid an improved inflation outlook.
  • Inflation projections were slashed to 2.6% from 3.1%, driven by GST reforms and benign food prices, creating policy space despite growth risks from 50% US tariffs.
  • Domestic demand raised the growth forecast to 6.8%, but H2 FY26 faces headwinds from trade tensions. The MPC adopts a wait-and-see approach before its next move.
This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.

Slogans, Propaganda or Actions?

By Thomas Lam

  • It is imperative to closely monitor the China economy in the current environment
  • My China Monthly Alternative Growth (CMAG) gauge provides a timely assessment of the aggregate economy
  • The CMAG is currently tracking below average in August, all else equal, with early indications of additional sogginess going forward

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars